BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS : revenue, balance sheet and financial ratios

BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS is a French company founded 6 years ago, specialized in the sector Activités des sièges sociaux. Based in LYON (69007), this company of category ETI shows in 2024 a revenue of 96 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS (SIREN 880035480)
Indicator 2024 2023 2022 2021 2020 2019
Revenue 96 000 € 96 000 € 96 000 € 96 000 € 96 000 € N/C
Net income 73 193 € 74 180 € 70 654 € 69 082 € 68 280 € -2 000 €
EBITDA 87 558 € 92 299 € 93 777 € 93 885 € 93 911 € -2 000 €
Net margin 76.2% 77.3% 73.6% 72.0% 71.1% N/C

Revenue and income statement

In 2024, BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS achieves revenue of 96 k€. Activity remains stable over the period (CAGR: 0.0%). Slight decline of 0% vs 2023. After deducting consumption (0 €), gross margin stands at 96 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 88 k€, representing 91.2% of revenue. Warning negative scissor effect: despite revenue change (+0%), EBITDA varies by -5%, reducing margin by 4.9 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 73 k€, i.e. 76.2% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

96 000 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

96 000 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

87 558 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

87 559 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

73 193 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

91.2%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 96%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 76.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

96.248%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

76.332%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS

Sector positioning

Debt ratio
0.0 2024
2022
2023
2024
Q1: 0.06
Med: 14.61
Q3: 89.57
Excellent

In 2024, the debt ratio of BOEHRINGER INGELHEIM ANIM... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
96.25% 2024
2022
2023
2024
Q1: 11.57%
Med: 51.97%
Q3: 85.24%
Excellent

In 2024, the financial autonomy of BOEHRINGER INGELHEIM ANIM... (96.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.2 years
Q3: 3.73 years
Excellent

In 2024, the repayment capacity of BOEHRINGER INGELHEIM ANIM... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2650.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2650.806

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS

Sector positioning

Liquidity ratio
2650.81 2024
2022
2023
2024
Q1: 116.63
Med: 458.65
Q3: 2184.57
Excellent

In 2024, the liquidity ratio of BOEHRINGER INGELHEIM ANIM... (2650.81) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2024
2022
2023
2024
Q1: -45.56x
Med: 0.0x
Q3: 2.85x
Good

In 2024, the interest coverage of BOEHRINGER INGELHEIM ANIM... (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 90 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 315 days. Excellent situation: suppliers finance 225 days of the operating cycle (retail model). Overall, WCR represents 1271 days of revenue, i.e. 339 k€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

339 040 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

90 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

315 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

1271 j

WCR and payment terms evolution
BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS

Positioning of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS in its sector

Comparison with sector Activités des sièges sociaux

Valuation estimate

Based on 103 transactions of similar company sales in 2024, the value of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS is estimated at 370 323 € (range 90 890€ - 761 127€). With an EBITDA of 87 558€, the sector multiple of 5.0x is applied. The price/revenue ratio is 0.38x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
103 transactions
90k€ 370k€ 761k€
370 323 € Range: 90 890€ - 761 127€
NAF 5 année 2024

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
87 558 € × 5.0x
Estimation 440 532 €
75 835€ - 728 775€
Revenue Multiple 30%
96 000 € × 0.38x
Estimation 36 251 €
17 278€ - 73 215€
Net Income Multiple 20%
73 193 € × 9.5x
Estimation 695 913 €
238 951€ - 1 873 876€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sièges sociaux)

Compare BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sièges sociaux

Frequently asked questions about BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS

What is the revenue of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS ?

The revenue of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS in 2024 is 96 k€.

Is BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS profitable?

Yes, BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS generated a net profit of 73 k€ in 2024.

Where is the headquarters of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS ?

The headquarters of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS is located in LYON (69007), in the department Rhone.

Where to find the tax return of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS ?

The tax return of BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS operate?

BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE COMMANDITE SAS operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.